The summary says
that, contrary to popular opinion, Dr
Wakefield was not the cause of the
MMR scare. Rather, his
hypothesis of a possible link between
MMR and autism was but one episode in
a much longer public health debate
about vaccine safety. His
participation in this debate was
conscientious, reasonable and
responsible for a research doctor in
his position.
Dr
Wakefields work on MMR and his
connections with the lawyers Dawbarns
and the Legal Aid Board (now the
Legal Services Commission) were
well known both in the general
media and amongst his colleagues from
an early stage.
Brian
Deer and his editors have a poor
understanding of Dr Wakefields
patent applications and the
underlying science and technology. In
fact, Dr Wakefields invention
[a single measles vaccine combined
with a treatment, possibly a
complete cure for autism]
could never compete with
MMR.
Brian
Deer and his editors have badly
misunderstood the quite separate
nature and purposes of the
ethical approval obtained at the
Royal Free hospital, known as 172/96,
a pilot study being performed for the
Legal Aid Board, and the paper
published in the Lancet in February
1998.
The
referral of children to the Royal
Free hospital was
orthodox, reflecting Dr
Wakefields well-known
interests, and children were not
recruited to the study.
When presented with a child
demonstrating regressive autism and
bowel symptoms the clinician is bound
to investigate the childs
symptoms. Beyond approving the
use of data derived from
investigations ethics approval
had little or no material role to
play.
Brian
Deer and his editors ignore
altogether that all clinical
decisions and procedures conducted in
relation to children were by
Professor Walker-Smith and his team,
in relation to gastrointestinal
investigations, and by other
appropriate specialist paediatric
practitioners in relation to, for
example, lumbar puncture.
Allegations
that the Royal Free hospital
laundered money from the
Legal Aid Board for Dr Wakefield's
research benefit are unfounded.
The
summary also made a number of other
points.